Research-use-only guide. It explains what KPV is and how to read supplier documents. It offers no dosing, administration or health advice. Supplier links are affiliate links; see below.
The last three letters of a hormone
If you line up the thirteen amino acids of alpha-melanocyte-stimulating hormone, alpha-MSH, you get a short chain that begins with an acetyl cap and ends with an amide: Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2. The hormone is best known for its role in skin pigmentation, signalling melanocytes to make melanin. It also has a second, less famous life as a regulator of inflammation, acting on immune cells and on tissues such as the gut and skin.
In the 1980s and 1990s, researchers took the hormone apart to find which piece does what. The pigmentation activity sits in the middle of the chain, around the His-Phe-Arg-Trp stretch. The anti-inflammatory activity, they found, lives at the other end, in the final three residues. Lys-Pro-Val, abbreviated KPV, reproduced much of the hormone's effect on inflammatory signalling in cell experiments while having no activity on pigmentation. That separation is what made the tripeptide interesting: a very small molecule, 342 daltons, carrying one function of a much larger hormone.
What the research reports
Published work on KPV is mostly laboratory-based. In cell-culture experiments, the tripeptide reduced the activation of NF-kappa-B, a master switch for inflammatory gene expression, and lowered release of inflammatory cytokines from stimulated cells. A notable line of work from groups studying intestinal inflammation examined KPV in mouse models of colitis. They reported that the tripeptide is taken up by a transporter called PepT1 that is abundant in the gut lining, and that it reduced markers of inflammation in the animals. Later experiments explored delivering KPV inside nanoparticles to target the gut specifically. Other reports examined skin and wound models.
That is a respectable body of preclinical work. It is also entirely preclinical. I am not aware of controlled human trials of KPV, and it holds no regulatory approval. As with every compound here, results in cultured cells and in mice do not establish what a substance does in people, and nothing on this page should be read as a claim of benefit. The takeaway for this guide is narrower: KPV is a well-defined, extremely short peptide with a coherent research story, which makes it comparatively easy to evaluate as a product.
When the molecule is this small, the paperwork should be perfect
Large peptides are forgiving of a little uncertainty because everything about them is a bit blurry. A tripeptide is not. It has three building blocks, a single main mass, and a chromatogram that should show one tall peak with almost nothing else. There are fewer places for impurities to hide and fewer excuses for a supplier. That makes KPV a good test of a supplier's quality system: if a company cannot document a three-residue peptide properly, that tells you something about how it will handle harder ones.
Specifically, a good KPV certificate should contain:
| Mass | About 342.4 Da (C16H30N4O4) for the free peptide. Because it is small, the observed ion is often reported as 343.4 for the protonated form. |
|---|---|
| Purity | A chromatogram with a dominant peak. For a tripeptide, high purity is easy to reach; values well below 98% are a poor sign. |
| Early peaks | Very polar small molecules elute near the start of the run. Impurities and leftover reagents often show up there, so check the trace's first minutes. |
| Salt and content | Acetate or TFA. For a molecule of only 342 daltons, a counter-ion makes up a large fraction of the weight, so net peptide content can be far below the label amount. |
| Form | Free acid or C-terminal amide. The amide is closer to the natural hormone and weighs about 1 Da less. |
| Batch details | Lot, test date, and the laboratory's name, matching the vial. |
The counter-ion point deserves emphasis. An acetate counter-ion adds 60 daltons to each charged site; a peptide with two basic groups can carry two of them. For a molecule of 342 daltons, that is a swing of tens of percent. A supplier that sells a 10 mg vial and states a peptide content of, say, 70 percent is giving you an honest and useful figure. One that does not say may be delivering the same material but leaves you guessing.
Why the free acid and amide forms matter
The natural hormone ends with a valine amide, and some research groups use the amidated tripeptide to mimic that. Others use the free acid. They are different compounds with slightly different masses and properties, and the literature is not perfectly consistent about which was used. If you are trying to match a specific paper, check its methods. If a supplier lists KPV without saying which form, ask. The difference is small on the page and potentially large in an experiment.
Stability, handling and what suppliers should say
Small peptides without cysteine, methionine or tryptophan are among the hardiest compounds in the catalog. KPV has none of the usual weak points, so freeze-dried powder stored cool and dry should keep for a long time. The main practical concern is moisture: short, polar peptides tend to be hygroscopic, and a poorly sealed vial can pick up water, which changes the true weight of peptide per milligram of powder. A supplier that seals vials carefully, states storage guidance and gives manufacturing or retest dates is doing what the chemistry calls for. Be a little wary of listings that promise very long shelf lives without evidence. Stability claims are cheap to write and expensive to test, and a stability study, even a simple one, is worth more than an assurance. It is another reason we read the documentation sections of supplier sites closely when we write reviews.
A note on sold-as-cosmetic versions
KPV also turns up in skincare product listings, usually at low concentrations alongside other ingredients. Those are formulated products, made to a different standard and aimed at a different use. They have no bearing on research-grade vials, and this page does not cover them.
Related short peptides
If you are exploring small, well-defined peptides, GHK-Cu is another tripeptide, though with a copper ion and a very different literature. Selank is a longer immune-derived peptide from a different tradition. A tripeptide should be easy to document; if you are interested in the opposite end of the spectrum, consider the 44-residue tesamorelin, where quality is much harder to assure.
Where to find it
Three suppliers in our directory list KPV. I have not ordered from any for this page; the notes reflect public listings.
Iron Peptides lists KPV. Code IRONMAN gives 10% off. See our Iron Peptides review; the company is also a sponsored listing on this site.
Next Gen Peps lists KPV in its catalog. It has not been reviewed on this site yet.
Vortex Research lists KPV and advertises the PEPPERS code at 30% off. It has not been reviewed on this site yet.
All three are affiliate links. PeptideSuppliers.org may earn a commission if you buy, at no extra cost to you. This does not influence our ratings, and the suppliers are listed alphabetically. See the disclosure page.
Short answers
Is KPV the same as alpha-MSH?
No. It is the last three residues of the thirteen-residue hormone, and lacks the part associated with pigmentation.
Why is a three-residue peptide worth a full COA?
Because it is so easy to analyse. A weak report on something this simple is informative about the supplier.
Is there human trial data?
I am not aware of controlled human trials; the published work is preclinical.
For every supplier we track, see the supplier database.
For laboratory research use only. Not medical advice; no claims about safety, legality or fitness for any use. See the medical disclaimer.